Chronic Graft versus Host Disease

Common Name(s)

Chronic Graft versus Host Disease

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Graft versus Host Disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Graft versus Host Disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chronic Graft versus Host Disease" returned 425 free, full-text research articles on human participants. First 3 results:

Chronic Graft-versus-host Disease Presenting with Multiple Punctate Intracranial Lesions on Contrast-enhanced Magnetic Resonance Imaging.
 

Author(s): Makoto Terada, Kiyotaka Nakamagoe, Naoshi Obara, Shinichi Ogawa, Noriaki Sakamoto, Taiki Sato, Seitaro Nohara, Shigeru Chiba, Akira Tamaoka

Journal: Intern. Med.. 2017 ;56(3):363-368.

 

Central nervous system graft-versus-host disease can present quite a diagnostic challenge. We herein present a case of histologically-confirmed chronic graft versus host disease (GVHD) involving the central nervous system that occurred at 19 months after peripheral blood stem cell ...

Last Updated: 3 Feb 2017

Go To URL
Phase I/IIa Study of Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host Disease.
 

Author(s): Takeru Asano, Ken-Ichi Matsuoka, Satoshi Iyama, Kazuteru Ohashi, Yoshihiro Inamoto, Chikako Ohwada, Makoto Murata, Atsushi Satake, Chikamasa Yoshida, Koichi Nakase, Yasuo Mori, Mitsune Tanimoto

Journal: Acta Med. Okayama. 2016 Oct;70(5):429-433.

 

Chronic graft versus host disease (cGVHD) remains a major problem for long survivors after allogeneic hematopoietic stem cell transplantation (HSCT). Currently, corticosteroid therapy is effective for cGVHD as the first line therapy. However, prolonged therapy with corticosteroids ...

Last Updated: 25 Oct 2016

Go To URL
An Open-labeled, Multicenter Phase II Study of Tamibarotene in Patients with Steroid-refractory Chronic Graft-versus-Host Disease.
 

Author(s): Yoshinobu Maeda, Hisakazu Nishimori, Yoshihiro Inamoto, Hirohisa Nakamae, Masashi Sawa, Yasuo Mori, Kazuteru Ohashi, Shin-Ichiro Fujiwara, Mitsune Tanimoto

Journal: Acta Med. Okayama. 2016 Oct;70(5):409-412.

 

Chronic graft-versus-host disease (GVHD) is a major cause of late death and morbidity following allogeneic hematopoietic cell transplantation (HSCT). Retinoic acid (tamibarotene) exerts multiple effects on cell differentiation and is clinically used for the treatment of acute promyelocytic ...

Last Updated: 25 Oct 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chronic Graft versus Host Disease" returned 47 free, full-text review articles on human participants. First 3 results:

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.
 

Author(s): Paul J Martin, Stephanie J Lee, Donna Przepiorka, Mary M Horowitz, John Koreth, Georgia B Vogelsang, Irwin Walker, Paul A Carpenter, Linda M Griffith, Gorgun Akpek, Mohamad Mohty, Daniel Wolff, Steven Z Pavletic, Corey S Cutler

Journal: Biol. Blood Marrow Transplant.. 2015 Aug;21(8):1343-59.

 

Treatment of chronic graft-versus-host disease is intended to produce a sustainable benefit by reducing symptom burden, controlling objective manifestations of disease activity, preventing damage and impairment, and improving overall survival without causing disproportionate harms ...

Last Updated: 17 Jul 2015

Go To URL
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.
 

Author(s): Sophie Paczesny, Frances T Hakim, Joseph Pidala, Kenneth R Cooke, Julia Lathrop, Linda M Griffith, John Hansen, Madan Jagasia, David Miklos, Steven Pavletic, Robertson Parkman, Estelle Russek-Cohen, Mary E D Flowers, Stephanie Lee, Paul Martin, Georgia Vogelsang, Marc Walton, Kirk R Schultz

Journal: Biol. Blood Marrow Transplant.. 2015 May;21(5):780-92.

 

Biology-based markers to confirm or aid in the diagnosis or prognosis of chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation or monitor its progression are critically needed to facilitate evaluation of new therapies. Biomarkers have been defined ...

Last Updated: 23 Apr 2015

Go To URL
NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.
 

Author(s): Howard M Shulman, Diana M Cardona, Joel K Greenson, Sangeeta Hingorani, Thomas Horn, Elisabeth Huber, Andreas Kreft, Thomas Longerich, Thomas Morton, David Myerson, Victor G Prieto, Avi Rosenberg, Nathaniel Treister, Kay Washington, Mirjana Ziemer, Steven Z Pavletic, Stephanie J Lee, Mary E D Flowers, Kirk R Schultz, Madan Jagasia, Paul J Martin, Georgia B Vogelsang, David E Kleiner

Journal: Biol. Blood Marrow Transplant.. 2015 Apr;21(4):589-603.

 

The 2005 National Institute of Health (NIH) Consensus Conference outlined histopathological diagnostic criteria for the major organ systems affected by both acute and chronic graft-versus-host disease (GVHD). The 2014 Consensus Conference led to this updated document with new information ...

Last Updated: 13 Mar 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 7 Jul 2016

Go to URL
Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells
 

Status: Recruiting

Condition Summary: Chronic Graft-Versus-Host Disease

 

Last Updated: 11 Nov 2014

Go to URL
Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease
 

Status: Recruiting

Condition Summary: Chronic Graft Versus Host Disease

 

Last Updated: 13 Dec 2016

Go to URL